17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Seyfarth Synopsis: Just before the end of the legislative session, lawmakers in New York introduced ...
Read More >
Union security and dues checkoff are both important subjects that come up during collective bargaini...
Read More >
On September 24, 2019, the U.S. Department of Labor (DOL) announced a final rule that, effective Jan...
Read More >
Our latest briefing focused on UK construction disputes summarises recent changes to court procedure...
Read More >
Millennials, can you relate to your older co-workers? Everybody and their dog has workshops these d...
Read More >
A volatile August on Wall Street has insiders asking whether we should be taking our cues from 1998 ...
Read More >